2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          High data quality is of crucial importance to the integrity of research projects. In the conduct of multi-center observational cohort studies with increasing types and quantities of data, maintaining data quality is challenging, with few published guidelines.

          Methods

          The Cure Glomerulonephropathy (CureGN) Network has established numerous quality control procedures to manage the 70 participating sites in the United States, Canada, and Europe. This effort is supported and guided by the activities of several committees, including Data Quality, Recruitment and Retention, and Central Review, that work in tandem with the Data Coordinating Center to monitor the study. We have implemented coordinator training and feedback channels, data queries of questionable or missing data, and developed performance metrics for recruitment, retention, visit completion, data entry, recording of patient-reported outcomes, collection, shipping and accessing of biological samples and pathology materials, and processing, cataloging and accessing genetic data and materials.

          Results

          We describe the development of data queries and site Report Cards, and their use in monitoring and encouraging excellence in site performance. We demonstrate improvements in data quality and completeness over 4 years after implementing these activities. We describe quality initiatives addressing specific challenges in collecting and cataloging whole slide images and other kidney pathology data, and novel methods of data quality assessment.

          Conclusions

          This paper reports the CureGN experience in optimizing data quality and underscores the importance of general and study-specific data quality initiatives to maintain excellence in the research measures of a multi-center observational study.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Robust relationship inference in genome-wide association studies.

          Genome-wide association studies (GWASs) have been widely used to map loci contributing to variation in complex traits and risk of diseases in humans. Accurate specification of familial relationships is crucial for family-based GWAS, as well as in population-based GWAS with unknown (or unrecognized) family structure. The family structure in a GWAS should be routinely investigated using the SNP data prior to the analysis of population structure or phenotype. Existing algorithms for relationship inference have a major weakness of estimating allele frequencies at each SNP from the entire sample, under a strong assumption of homogeneous population structure. This assumption is often untenable. Here, we present a rapid algorithm for relationship inference using high-throughput genotype data typical of GWAS that allows the presence of unknown population substructure. The relationship of any pair of individuals can be precisely inferred by robust estimation of their kinship coefficient, independent of sample composition or population structure (sample invariance). We present simulation experiments to demonstrate that the algorithm has sufficient power to provide reliable inference on millions of unrelated pairs and thousands of relative pairs (up to 3rd-degree relationships). Application of our robust algorithm to HapMap and GWAS datasets demonstrates that it performs properly even under extreme population stratification, while algorithms assuming a homogeneous population give systematically biased results. Our extremely efficient implementation performs relationship inference on millions of pairs of individuals in a matter of minutes, dozens of times faster than the most efficient existing algorithm known to us. Our robust relationship inference algorithm is implemented in a freely available software package, KING, available for download at http://people.virginia.edu/∼wc9c/KING.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

            Glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and immunoglobulin A (IgA) nephropathy, share clinical presentations, yet result from multiple biological mechanisms. Challenges to identifying underlying mechanisms, biomarkers, and new therapies include the rarity of each diagnosis and slow progression, often requiring decades to measure the effectiveness of interventions to prevent end-stage kidney disease (ESKD) or death.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Digital pathology imaging as a novel platform for standardization and globalization of quantitative nephropathology

              Abstract The introduction of digital pathology to nephrology provides a platform for the development of new methodologies and protocols for visual, morphometric and computer-aided assessment of renal biopsies. Application of digital imaging to pathology made substantial progress over the past decade; it is now in use for education, clinical trials and translational research. Digital pathology evolved as a valuable tool to generate comprehensive structural information in digital form, a key prerequisite for achieving precision pathology for computational biology. The application of this new technology on an international scale is driving novel methods for collaborations, providing unique opportunities but also challenges. Standardization of methods needs to be rigorously evaluated and applied at each step, from specimen processing to scanning, uploading into digital repositories, morphologic, morphometric and computer-aided assessment, data collection and analysis. In this review, we discuss the status and opportunities created by the application of digital imaging to precision nephropathology, and present a vision for the near future.
                Bookmark

                Author and article information

                Contributors
                Journal
                Contemp Clin Trials Commun
                Contemp Clin Trials Commun
                Contemporary Clinical Trials Communications
                Elsevier
                2451-8654
                17 February 2021
                June 2021
                17 February 2021
                : 22
                : 100749
                Affiliations
                [a ]Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA
                [b ]Division of Nephrology, Maisonneuve-Rosemont Hospital, Department of Medicine, University of Montreal, Montreal, Quebec, Canada
                [c ]Arbor Research Collaborative for Health, Ann Arbor, MI, 48104, USA
                [d ]Stanford University Medical Center, Stanford, CA, 94305, USA
                [e ]Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
                [f ]Pediatrics-Renal, Baylor College of Medicine, Houston, TX, USA
                [g ]NYU Langone Health, Department of Pediatrics, Division of Nephrology, New York, NY, USA
                [h ]Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
                [i ]Department of Pathology, Division of AI and Computational Pathology, Department of Medicine, Division of Nephrology, Duke University, Durham, NC, USA
                [j ]Laboratory of Molecular Nephrology, Istituto Giannina Gaslini, IRCCS, Genoa, Italy
                [k ]Emory University, Department of Pediatrics, Division of Nephrology, Atlanta, GA, USA
                [l ]Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
                [m ]University of Michigan, Division of Nephrology, Ann Arbor, MI, USA
                [n ]Center for Clinical and Translational Research, the Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA
                [o ]Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA
                [p ]University of Michigan, Division of Nephrology, Department of Pediatrics, Ann Arbor, MI, USA
                [q ]Arbor Research Collaborative for Health, Ann Arbor, MI, USA
                [r ]Center for Translational Research, Children's National Hospital, Washington, DC, USA
                Author notes
                []Corresponding author. 3550 Rackham Bldg.; 915 E. Washington; Ann Arbor, MI, 48109, USA. bgillesp@ 123456umich.edu
                Article
                S2451-8654(21)00051-X 100749
                10.1016/j.conctc.2021.100749
                8039553
                33851061
                3f5ace1c-9530-48bc-a275-8589ab02a009
                © 2021 Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 28 June 2020
                : 16 January 2021
                : 9 February 2021
                Categories
                Article

                data quality,quality metrics,site performance,observational studies,kidney disease

                Comments

                Comment on this article